SecBot SecBot
PRESS-RELEASE ·Filed Mar 16, 2026

CTMX

CytomX Therapeutics Inc.
BEARISH
Impact 7/10
Horizondays Processed8mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

Traders should anticipate near-term downward pressure on CTMX shares due to dilution concerns; monitor for pricing and final size of the offering. Consider hedging or reducing positions ahead of pricing.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$5.45
T+0 close · Mar 16, 2026 · via day close
Latest settled
−45.32%
T+60 · $2.98
Vs SPY
−55.18%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 17 $5.45entry
  2. T+1 · 8mo ago −19.27%α −17.87% · $4.40
  3. T+5 · 8mo ago −22.20%α −19.55% · $4.24
  4. T+20 · 7mo ago −16.33%α −20.63% · $4.56
  5. T+60 · 5mo ago −45.32%α −55.18% · $2.98
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CytomX Therapeutics announced a public offering of $250.0 million in common stock and pre-funded warrants, with an additional $37.5 million option for underwriters to purchase more shares. The offering is expected to dilute existing shareholders and is subject to market conditions.

Key Financial Metrics

Deal Value
$250.0M

Key Facts

  • CytomX announced a public offering of $250.0 million in common stock and pre-funded warrants.
  • Underwriters have a 30-day option to purchase up to an additional $37.5 million in shares.
  • All securities are being offered directly by CytomX, indicating primary issuance and not a secondary sale.
  • Proceeds will likely be used for general corporate purposes, R&D, or clinical trial funding, though specific use was not detailed in the release.
  • The offering represents significant dilution to existing shareholders, especially if the full $287.5 million is raised.

Financial Impact

$250.0 million raised, potentially $287.5 million with overallotment; significant dilution expected

dilutioncashequity

Risk Factors

  • Dilution from new share issuance could negatively impact stock price.
  • Market conditions may delay or reduce the size of the offering, creating uncertainty.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3256708

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 16, 2026